Koninklijke Philips N.V. (PHG)
- Previous Close
26.49 - Open
26.12 - Bid --
- Ask --
- Day's Range
26.10 - 26.50 - 52 Week Range
17.75 - 29.44 - Volume
1,078,277 - Avg. Volume
1,179,560 - Market Cap (intraday)
24.762B - Beta (5Y Monthly) 0.69
- PE Ratio (TTM)
-- - EPS (TTM)
-0.90 - Earnings Date Jul 29, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date May 12, 2022
- 1y Target Est
22.87
Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease. In addition, the company offers acute patient management solutions; emergency care solutions; sleep and respiratory care solutions; and electronic medical record and care management solutions. Further, it provides power toothbrushes, brush heads, and interdental cleaning and teeth whitening products; infant feeding, baby monitors, and digital parental solutions; and grooming and beauty products and solutions. The company has strategic partnership agreements with TriHealth, Northwell, and Atrium Health. The company was formerly known as Koninklijke Philips Electronics N.V. and changed its name to Koninklijke Philips N.V. in May 2013. Koninklijke Philips N.V. was founded in 1891 and is headquartered in Amsterdam, the Netherlands.
www.philips.comRecent News: PHG
Performance Overview: PHG
Trailing total returns as of 6/6/2024, which may include dividends or other distributions. Benchmark is
.YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: PHG
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: PHG
Valuation Measures
Market Cap
24.76B
Enterprise Value
31.01B
Trailing P/E
--
Forward P/E
16.64
PEG Ratio (5yr expected)
0.41
Price/Sales (ttm)
1.31
Price/Book (mrq)
1.88
Enterprise Value/Revenue
1.57
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-4.41%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
18.14B
Net Income Avi to Common (ttm)
-794M
Diluted EPS (ttm)
-0.90
Balance Sheet and Cash Flow
Total Cash (mrq)
1.87B
Total Debt/Equity (mrq)
63.75%
Levered Free Cash Flow (ttm)
--
Research Analysis: PHG
Company Insights: PHG
PHG does not have Company Insights
Research Reports: PHG
Philips Earnings: Reaches $1.1 Billion Settlement Agreement; Maintaining EUR 21 Fair Value Estimate
Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. Around 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound equipment, image-guided therapy solutions and healthcare informatics. The connected care segment (around 30% of revenue) encompasses monitoring and analytics systems for hospitals and sleep and respiratory care devices, whereas the personal health business (remainder of revenue) includes electric toothbrushes and men's grooming and personal-care products.
RatingPrice TargetPhilips Earnings: Reaches $1.1 Billion Settlement Agreement; Maintaining EUR 21 Fair Value Estimate
Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. Around 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound equipment, image-guided therapy solutions and healthcare informatics. The connected care segment (around 30% of revenue) encompasses monitoring and analytics systems for hospitals and sleep and respiratory care devices, whereas the personal health business (remainder of revenue) includes electric toothbrushes and men's grooming and personal-care products.
RatingPrice TargetPhilips Earnings: New Restrictions Weigh on Sleep and Respiratory Business; Fair Value Down 16%
Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. Around 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound equipment, image-guided therapy solutions and healthcare informatics. The connected care segment (around 30% of revenue) encompasses monitoring and analytics systems for hospitals and sleep and respiratory care devices, whereas the personal health business (remainder of revenue) includes electric toothbrushes and men's grooming and personal-care products.
RatingPrice TargetPhilips Shares Undervalued, but Raising Uncertainty Rating to High
Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. Around 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound equipment, image-guided therapy solutions and healthcare informatics. The connected care segment (around 30% of revenue) encompasses monitoring and analytics systems for hospitals and sleep and respiratory care devices, whereas the personal health business (remainder of revenue) includes electric toothbrushes and men's grooming and personal-care products.
RatingPrice Target